1.66
+0.11(+7.10%)
Currency In USD
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
95
First IPO Date
May 20, 2020
| Name | Title | Pay | Year Born |
| Mr. Eyal Fisher | Chief Executive Officer of the IMC Holdings | 210,811 | N/A |
| Mr. Richard Balla | Chief Executive Officer of Adjupharm | 222,436 | N/A |
| Mr. Oren Shuster | Chief Executive Officer & Executive Director | 343,849 | N/A |
| Advocate Michal Lebovitz Nissimov | General Counsel & Secretary | 136,829 | N/A |
| Mr. Uri Birenberg | Chief Financial Officer | 252,764 | 1976 |
| Anna Taranko | Director Investor & Public Relations | 0 | N/A |
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
